Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia

American Journal of Epidemiology
Alana T BrennanMatthew P Fox

Abstract

Tenofovir is less toxic than other nucleoside reverse-transcriptase inhibitors used in antiretroviral therapy (ART) and may improve retention of human immunodeficiency virus (HIV)-infected patients on ART. We assessed the impact of national guideline changes in South Africa (2010) and Zambia (2007) recommending tenofovir for first-line ART. We applied regression discontinuity in a prospective cohort study of 52,294 HIV-infected adults initiating first-line ART within 12 months (±12 months) of each guideline change. We compared outcomes in patients presenting just before and after the guideline changes using local linear regression and estimated intention-to-treat effects on initiation of tenofovir, retention in care, and other treatment outcomes at 24 months. We assessed complier causal effects among patients starting tenofovir. The new guidelines increased the percentages of patients initiating tenofovir in South Africa (risk difference (RD) = 81 percentage points, 95% confidence interval (CI): 73, 89) and Zambia (RD = 42 percentage points, 95% CI: 38, 45). With the guideline change, the percentage of single-drug substitutions decreased substantially in South Africa (RD = -15 percentage points, 95% CI: -18, -12). Starting teno...Continue Reading

References

Jul 14, 2004·JAMA : the Journal of the American Medical Association·Joel E GallantUNKNOWN 903 Study Group
Dec 13, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nagalingeswaran KumarasamyKenneth H Mayer
Aug 28, 2007·HIV Clinical Trials·Sandra A SpringerFrederick L Altice
Jan 10, 2008·The Journal of Infectious Diseases·Richard A MurphyRajesh T Gandhi
Jun 3, 2008·The Journal of Infectious Diseases·Thi Tuyet Nhung VoUNKNOWN Swiss HIV Cohort Study
Jun 4, 2008·AIDS·Rebecca K LodwickAndrew N Phillips
Mar 12, 2009·Health Policy and Planning·B S C UzochukwuO I Chukwuogo
Dec 17, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benjamin H ChiJeffrey S A Stringer
Feb 9, 2010·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Hamilton DomingosAlbert Schiaveto de Souza
Aug 20, 2010·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN U.S. Food And Drug Administration
Nov 3, 2010·Antiviral Therapy·Amandine CournilChristian Laurent
Dec 18, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Helen BygraveKatharina Kranzer
May 20, 2011·International Journal of Epidemiology·Matthias EggerKara Wools-Kaloustian
Jul 21, 2012·Antiviral Therapy·Charles F GilksUNKNOWN DART Virology Group and Trial Team
Aug 9, 2012·BMJ : British Medical Journal·Donald W Light, Joel R Lexchin
Dec 21, 2013·Human Vaccines & Immunotherapeutics·Eva BorràsUNKNOWN Working Group for the Study of the Immune Status in Healthcare Workers
Mar 5, 2014·Tropical Medicine & International Health : TM & IH·Alana T BrennanMatthew P Fox
Feb 3, 2015·Epidemiology·Jacob BorTill Bärnighausen
Sep 16, 2015·Current Opinion in HIV and AIDS·Jacob BorTill Bärnighausen
Oct 2, 2015·The Lancet. HIV·Nicholas I PatonUNKNOWN Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team
May 27, 2017·Médecine et maladies infectieuses·P A CoffieG Wandeler
Aug 30, 2017·Depression Research and Treatment·UNKNOWN Depression Research And Treatment

❮ Previous
Next ❯

Citations

Nov 26, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jacob Bor, Harsha Thirumurthy
Dec 28, 2018·Implementation Science : IS·H Manisha Yapa, Till Bärnighausen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.